Some have relabeled it as Pentadecapeptide Aringate or PDA (shifting the acetate to an arginate) and are prescribing it for subcutaneous administration that way, although the confusion about its position has triggered a lively oral capsule marketplace for BPC in what seems to become a grey spot of legality.The draw back of BPC-157 is that it is how… Read More